Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Study of Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation Therapy in Advanced Metastatic Disease

NCT02843165 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT02843165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02843165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Study of Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation Therapy in Advanced Metastatic Disease
Lead sponsor
University of California, San Diego
Phase
Phase 2
Overall status
Completed
Start date
September 2, 2016
Completion date
August 15, 2024
Enrollment
106 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer